Connor, Clark & Lunn Investment Management Ltd.
Position in BMY — Bristol Myers Squibb Co
CIK 1596800
VANCOUVER, A1
Position in BMY
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$66,750,722
+$65,696,876 QoQ
Shares Held
1,100,589
+6269.5% QoQ
Ownership
0.054%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
18 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Connor, Clark & Lunn Investment Management Ltd. holds $830,990,729 across 11 Drug Manufacturers - General names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
173,392 | $207,971,583 | |
| 2 | ABBV |
AbbVie Inc.
|
751,485 | $189,103,685 | |
| 3 | GSK |
GSK plc
|
2,767,591 | $145,077,119 | |
| 4 | NVS |
Novartis AG
|
740,532 | $116,056,174 | |
| 5 | SNY |
Sanofi
|
1,835,859 | $78,317,744 | |
| 6 | JNJ |
Johnson & Johnson
|
307,423 | $78,076,219 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
46,429 | $5,865,839 | |
| 8 | MRK |
Merck & Co., Inc.
|
38,087 | $4,894,179 |
All Filings in BMY
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $66,750,722 | 1,100,589 | Shares | Sole | 2026-05-11 | |
| 2025-03-31 | $1,053,846 | 17,279 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $10,542,501 | 186,395 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $3,578,907 | 69,171 | Shares | Sole | 2024-11-08 | |
| 2024-03-31 | $2,216,542 | 40,873 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $77,069,313 | 1,502,033 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $65,548,286 | 1,129,364 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,533,635 | 39,619 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,537,018 | 22,176 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $34,858,192 | 484,478 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $1,522,321 | 21,414 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $20,632,458 | 267,954 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $62,230,688 | 852,125 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $45,632,468 | 731,876 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $3,235,119 | 54,675 | Shares | Sole | 2021-11-12 | |
| 2020-09-30 | $21,479,216 | 356,265 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $46,020,408 | 782,660 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $45,687,291 | 819,650 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||